Overview
Focal, segmental, or multifocal dystonia refers to a group of movement disorders characterized by sustained or intermittent muscle contractions causing abnormal, often repetitive movements, postures, or both. In focal dystonia, a single body region is affected (such as the neck in cervical dystonia/torticollis, the eyelids in blepharospasm, or the hand in writer's cramp). Segmental dystonia involves two or more contiguous body regions, while multifocal dystonia affects two or more non-contiguous body regions. These forms are distinguished from generalized dystonia, which involves the trunk and at least two other body regions. The condition primarily affects the nervous system, specifically the motor control circuits involving the basal ganglia, cerebellum, and their cortical connections. Symptoms typically include involuntary twisting or repetitive movements, abnormal postures, tremor, and pain in the affected regions. The severity can range from mild, task-specific symptoms (such as dystonia triggered only during writing or playing a musical instrument) to more disabling forms that significantly impair daily activities. Sensory tricks (geste antagoniste), where touching or applying pressure to the affected area temporarily alleviates symptoms, are a characteristic feature. Treatment options include botulinum toxin injections, which are considered the first-line therapy for focal and segmental forms and can provide significant symptom relief. Oral medications such as anticholinergics (e.g., trihexyphenidyl), baclofen, and benzodiazepines may be used as adjunctive therapies. Physical therapy and occupational therapy can help manage symptoms and maintain function. In refractory cases, deep brain stimulation (DBS) targeting the globus pallidus internus may be considered. The condition is generally chronic, and treatment is symptomatic rather than curative.
Variable
Can be inherited in different ways depending on the underlying gene
Adult
Begins in adulthood (age 18 or older)
FDA & Trial Timeline
4 eventsVima Therapeutics — PHASE2
University of Maryland, Baltimore — NA
MGH Institute of Health Professions — NA
National Institute of Neurological Disorders and Stroke (NINDS) — PHASE1, PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Focal, segmental or multifocal dystonia.
3 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Focal, segmental or multifocal dystonia.
Community
No community posts yet. Be the first to share your experience with Focal, segmental or multifocal dystonia.
Start the conversation →Latest news about Focal, segmental or multifocal dystonia
Disease timeline:
New recruiting trial: MRgFUS Pallidotomy for the Treatment of Task Specific Focal Hand Dystonia (TSFD)
A new clinical trial is recruiting patients for Focal, segmental or multifocal dystonia
New recruiting trial: A Study to Evaluate the Efficacy, Safety, and Tolerability of VIM0423 in Individuals With Isolated Dystonia
A new clinical trial is recruiting patients for Focal, segmental or multifocal dystonia
New recruiting trial: Effects of Neuromodulation in Laryngeal Dystonia
A new clinical trial is recruiting patients for Focal, segmental or multifocal dystonia
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Focal, segmental or multifocal dystonia
What is Focal, segmental or multifocal dystonia?
Focal, segmental, or multifocal dystonia refers to a group of movement disorders characterized by sustained or intermittent muscle contractions causing abnormal, often repetitive movements, postures, or both. In focal dystonia, a single body region is affected (such as the neck in cervical dystonia/torticollis, the eyelids in blepharospasm, or the hand in writer's cramp). Segmental dystonia involves two or more contiguous body regions, while multifocal dystonia affects two or more non-contiguous body regions. These forms are distinguished from generalized dystonia, which involves the trunk and
At what age does Focal, segmental or multifocal dystonia typically begin?
Typical onset of Focal, segmental or multifocal dystonia is adult. Age of onset can vary across affected individuals.
Are there clinical trials for Focal, segmental or multifocal dystonia?
Yes — 3 recruiting clinical trials are currently listed for Focal, segmental or multifocal dystonia on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Focal, segmental or multifocal dystonia?
19 specialists and care centers treating Focal, segmental or multifocal dystonia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.